Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

313.34
Delayed Data
As of Jul 29
 -6.59 / -2.06%
Today’s Change
290.85
Today|||52-Week Range
480.18
-7.69%
Year-to-Date

Today’s Trading

Previous close319.93
Today’s open321.92
Day’s range309.15 - 323.00
Volume3,278,003
Average volume (3 months)1,918,200
Market cap$75.2B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+15.46%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+39.61%
P/E ratio21.2
Price/Sales8.30
Price/Book6.94

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.41+1.08%
BXLTBaxalta Inc+0.48+1.58%
AMGNAmgen-1.27-0.74%
XONIntrexon Corp+1.74+2.87%
Data as of 4:05pm ET, 07/29/2015

Financials

Next reporting dateOctober 20, 2015
EPS forecast (this quarter)$3.94
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts